Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Lane

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Protein Engineering, Design & Selection : PEDS|October 23, 2015
Engineering a genetically encoded competitive inhibitor of the KEAP1-NRF2 interaction via structure-based design and phage displayGurkan Guntas, Steven M Lewis, Kathleen M Mulvaney, et al.
Molecules (Basel, Switzerland)|May 14, 2025
Development and Characterization of pFluor50, a Fluorogenic-Based Kinetic Assay System for High-Throughput Inhibition Screening and Characterization of Time-Dependent Inhibition and Inhibition Type for Six Human CYPsPratik Shriwas, Andre Revnew, Sarah Roo, et al.
Plos Neglected Tropical Diseases|November 22, 2019
Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infectionThomas R Lane, Christopher Massey, Jason E Comer, et al.
Molecular Pharmaceutics|March 20, 2025
Computational Approaches for Predicting Drug Interactions with Human Organic Anion Transporter 4 (OAT4)Lucy Martinez-Guerrero, Patricia A Vignaux, Joshua S Harris, et al.
ACS Omega|November 6, 2023
Synthesis and Evaluation of 9-Aminoacridines with SARS-CoV-2 Antiviral ActivityThane Jones, Natalia Monakhova, Florence Guivel-Benhassine, et al.
ACS Omega|September 9, 2024
Oral Pyronaridine Tetraphosphate Reduces Tissue Presence of Parasites in a Mouse Model of Chagas DiseaseJair Lage Siqueira-Neto, Thomas R Lane, Jean A Bernatchez, et al.
Nature Materials|April 20, 2019
Exploiting machine learning for end-to-end drug discovery and developmentSean Ekins, Ana C Puhl, Kimberley M Zorn, et al.
Communications Chemistry|June 12, 2024
The Goldilocks paradigm: comparing classical machine learning, large language models, and few-shot learning for drug discovery applicationsScott H Snyder, Patricia A Vignaux, Mustafa Kemal Ozalp, et al.
ACS Omega|November 30, 2020
Computational Approaches to Identify Molecules Binding to <i>Mycobacterium tuberculosis</i> KasAAna C Puhl, Thomas R Lane, Patricia A Vignaux, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 19, 2025
Machine Learning Modeling of Zebrafish Toxicity Endpoints After Exposure to PROTACsChristopher Yogodzinski, Joshua S Harris, Thomas R Lane, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Protein Engineering, Design & Selection : PEDS|October 23, 2015
Engineering a genetically encoded competitive inhibitor of the KEAP1-NRF2 interaction via structure-based design and phage displayGurkan Guntas, Steven M Lewis, Kathleen M Mulvaney, et al.
Molecules (Basel, Switzerland)|May 14, 2025
Development and Characterization of pFluor50, a Fluorogenic-Based Kinetic Assay System for High-Throughput Inhibition Screening and Characterization of Time-Dependent Inhibition and Inhibition Type for Six Human CYPsPratik Shriwas, Andre Revnew, Sarah Roo, et al.
Plos Neglected Tropical Diseases|November 22, 2019
Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infectionThomas R Lane, Christopher Massey, Jason E Comer, et al.
Molecular Pharmaceutics|March 20, 2025
Computational Approaches for Predicting Drug Interactions with Human Organic Anion Transporter 4 (OAT4)Lucy Martinez-Guerrero, Patricia A Vignaux, Joshua S Harris, et al.
ACS Omega|November 6, 2023
Synthesis and Evaluation of 9-Aminoacridines with SARS-CoV-2 Antiviral ActivityThane Jones, Natalia Monakhova, Florence Guivel-Benhassine, et al.
ACS Omega|September 9, 2024
Oral Pyronaridine Tetraphosphate Reduces Tissue Presence of Parasites in a Mouse Model of Chagas DiseaseJair Lage Siqueira-Neto, Thomas R Lane, Jean A Bernatchez, et al.
Nature Materials|April 20, 2019
Exploiting machine learning for end-to-end drug discovery and developmentSean Ekins, Ana C Puhl, Kimberley M Zorn, et al.
Communications Chemistry|June 12, 2024
The Goldilocks paradigm: comparing classical machine learning, large language models, and few-shot learning for drug discovery applicationsScott H Snyder, Patricia A Vignaux, Mustafa Kemal Ozalp, et al.
ACS Omega|November 30, 2020
Computational Approaches to Identify Molecules Binding to <i>Mycobacterium tuberculosis</i> KasAAna C Puhl, Thomas R Lane, Patricia A Vignaux, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 19, 2025
Machine Learning Modeling of Zebrafish Toxicity Endpoints After Exposure to PROTACsChristopher Yogodzinski, Joshua S Harris, Thomas R Lane, et al.
Pageof 8